Actonel (risedronate) is now approved for osteoporosis

May 2000

Actonel (risedronate) is now approved for osteoporosis.

Actonel is a bisphosphonate...similar to Fosamax (alendronate). But until now, Actonel was approved only for Paget's disease.

The new indication is to prevent or treat osteoporosis in postmenopausal women...or in patients taking glucocorticoids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

most drugs remain safe and effective long after their expiration date
Cardiology NSAIDs contribute to congestive heart failure (CHF) in elderly patients
Cardiology changing the generic name "amrinone" to "inamrinone"
Osteoporosis Actonel (risedronate) is now approved for osteoporosis
new dietary recommendations for antioxidants
Neurology & Pain new seizure drug called Zonegran (zonisamide)
Infectious Diseases penicillin TWICE DAILY for Strep throat
Infectious Diseases Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections
Infectious Diseases tricks to minimize the adverse CNS effects that patients get when they start Sustiva (efavirenz)
Gastroenterology alternative to Propulsid for heartburn and other GI disorders
Gastroenterology new drug for severe dry mouth called Evoxac (EE-vo-zak, cevimeline)
Men's Health Uprima (you-PREE-ma), a new prescription alternative to Viagra
two new light-activated drugs
universal Rx benefit card
Supplements vitamin C to help PREVENT the rare nerve disorder that occurs after an injury or fracture